Dyrk2 Antibodies

Santa Cruz Biotechnology delivers a wide array of Dyrk2 monoclonal antibodies for research focused on dual-specificity tyrosine phosphorylation-regulated kinase 2 (Dyrk2). Dyrk2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Dyrk2 plays essential roles in cellular processes, including cell proliferation, differentiation, and apoptosis. Dysregulation of Dyrk2 has been linked to various diseases, including neurodegenerative disorders and cancer, making it a significant target for therapeutic intervention. Understanding Dyrk2 function and regulation is crucial for advancing knowledge of these pathological conditions. Researchers can utilize specific monoclonal antibodies conjugated with horseradish peroxidase (HRP), phycoerythrin (PE), or fluorescein isothiocyanate (FITC) for enhanced detection flexibility. Advanced research techniques and protocols have revealed new insights into Dyrk2's molecular mechanisms and signaling pathways. Ongoing studies continue to uncover novel functions and regulatory mechanisms of Dyrk2 in both normal and disease states. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of Dyrk2's role in human health and disease.